Cut generics costs, save $1.3 billion: report

In its report, Australia’s bad drug deal — High pharmaceutical prices, the Grattan Institute said Australia had been too “timid” with drug companies, and should be demanding a better price for generic medicines through a new pharmaceutical agency.

Comparing Australia to New Zealand, which has an independent Pharmaceutical Management Agency, it found Australia’s wholesale drug prices were, on average, six times higher, and in some cases 20 times